메뉴 건너뛰기




Volumn 9, Issue 389, 2017, Pages

In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; FC RECEPTOR IIB; PROGRAMMED DEATH 1 RECEPTOR; FC RECEPTOR; MONOCLONAL ANTIBODY;

EID: 85019200410     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aal3604     Document Type: Article
Times cited : (501)

References (52)
  • 1
    • 0029947568 scopus 로고    scopus 로고
    • Enhancement of antitumor immunity by CTLA-4 blockade
    • D. R. Leach, M. F. Krummel, J. P. Allison, Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734-1736 (1996).
    • (1996) Science , vol.271 , pp. 1734-1736
    • Leach, D.R.1    Krummel, M.F.2    Allison, J.P.3
  • 2
    • 84858766182 scopus 로고    scopus 로고
    • The blockade of immune checkpoints in cancer immunotherapy
    • D. M. Pardoll, The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252-264 (2012).
    • (2012) Nat. Rev. Cancer , vol.12 , pp. 252-264
    • Pardoll, D.M.1
  • 3
    • 84928062583 scopus 로고    scopus 로고
    • Immune checkpoint blockade: A common denominator approach to cancer therapy
    • S. L. Topalian, C. G. Drake, D. M. Pardoll, Immune checkpoint blockade: A common denominator approach to cancer therapy. Cancer Cell 27, 450-461 (2015).
    • (2015) Cancer Cell , vol.27 , pp. 450-461
    • Topalian, S.L.1    Drake, C.G.2    Pardoll, D.M.3
  • 4
    • 84938350452 scopus 로고    scopus 로고
    • Combination cancer immunotherapy and new immunomodulatory targets
    • K. M. Mahoney, P. D. Rennert, G. J. Freeman, Combination cancer immunotherapy and new immunomodulatory targets. Nat. Rev. Drug Discov. 14, 561-584 (2015).
    • (2015) Nat. Rev. Drug Discov. , vol.14 , pp. 561-584
    • Mahoney, K.M.1    Rennert, P.D.2    Freeman, G.J.3
  • 6
    • 79953151458 scopus 로고    scopus 로고
    • Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion
    • R. D. Schreiber, L. J. Old, M. J. Smyth, Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science 331, 1565-1570 (2011).
    • (2011) Science , vol.331 , pp. 1565-1570
    • Schreiber, R.D.1    Old, L.J.2    Smyth, M.J.3
  • 7
    • 84880706152 scopus 로고    scopus 로고
    • Oncology meets immunology: The cancer-immunity cycle
    • D. S. Chen, I. Mellman, Oncology meets immunology: The cancer-immunity cycle. Immunity 39, 1-10 (2013).
    • (2013) Immunity , vol.39 , pp. 1-10
    • Chen, D.S.1    Mellman, I.2
  • 12
    • 84928770388 scopus 로고    scopus 로고
    • Neoantigens in cancer immunotherapy
    • T. N. Schumacher, R. D. Schreiber, Neoantigens in cancer immunotherapy. Science 348, 69-74 (2015).
    • (2015) Science , vol.348 , pp. 69-74
    • Schumacher, T.N.1    Schreiber, R.D.2
  • 13
    • 84920962202 scopus 로고    scopus 로고
    • Molecular and genetic properties of tumors associated with local immune cytolytic activity
    • M. S. Rooney, S. A. Shukla, C. J. Wu, G. Getz, N. Hacohen, Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48-61 (2015).
    • (2015) Cell , vol.160 , pp. 48-61
    • Rooney, M.S.1    Shukla, S.A.2    Wu, C.J.3    Getz, G.4    Hacohen, N.5
  • 15
    • 84962840922 scopus 로고    scopus 로고
    • Combination cancer therapies with immune checkpoint blockade: Convergence on interferon signaling
    • A. J. Minn, E. J. Wherry, Combination cancer therapies with immune checkpoint blockade: Convergence on interferon signaling. Cell 165, 272-275 (2016).
    • (2016) Cell , vol.165 , pp. 272-275
    • Minn, A.J.1    Wherry, E.J.2
  • 16
    • 84886698315 scopus 로고    scopus 로고
    • Innate and adaptive immune cells in the tumor microenvironment
    • T. F. Gajewski, H. Schreiber, Y.-X. Fu, Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14, 1014-1022 (2013).
    • (2013) Nat. Immunol. , vol.14 , pp. 1014-1022
    • Gajewski, T.F.1    Schreiber, H.2    Fu, Y.-X.3
  • 17
    • 84904406680 scopus 로고    scopus 로고
    • Tumor-associated macrophages: From mechanisms to therapy
    • R. Noy, J. W. Pollard, Tumor-associated macrophages: From mechanisms to therapy. Immunity 41, 49-61 (2014).
    • (2014) Immunity , vol.41 , pp. 49-61
    • Noy, R.1    Pollard, J.W.2
  • 18
    • 84976272206 scopus 로고    scopus 로고
    • The role of myeloid cells in cancer therapies
    • C. Engblom, C. Pfirschke, M. J. Pittet, The role of myeloid cells in cancer therapies. Nat. Rev. Cancer 16, 447-462 (2016).
    • (2016) Nat. Rev. Cancer , vol.16 , pp. 447-462
    • Engblom, C.1    Pfirschke, C.2    Pittet, M.J.3
  • 19
    • 58149314579 scopus 로고    scopus 로고
    • NFATc1 regulates PD-1 expression upon T cell activation
    • K. J. Oestreich, H. Yoon, R. Ahmed, J. M. Boss, NFATc1 regulates PD-1 expression upon T cell activation. J. Immunol. 181, 4832-4839 (2008).
    • (2008) J. Immunol. , vol.181 , pp. 4832-4839
    • Oestreich, K.J.1    Yoon, H.2    Ahmed, R.3    Boss, J.M.4
  • 24
    • 28544449847 scopus 로고    scopus 로고
    • Divergent immunoglobulin g subclass activity through selective Fc receptor binding
    • F. Nimmerjahn, J. V. Ravetch, Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310, 1510-1512 (2005).
    • (2005) Science , vol.310 , pp. 1510-1512
    • Nimmerjahn, F.1    Ravetch, J.V.2
  • 25
    • 84942306499 scopus 로고    scopus 로고
    • FcγRs modulate the anti-tumor activity of antibodies targeting the PD-1/PD-L1 axis
    • R. Dahan, E. Sega, J. Engelhardt, M. Selby, A. J. Korman, J. V. Ravetch, FcγRs modulate the anti-tumor activity of antibodies targeting the PD-1/PD-L1 axis. Cancer Cell 28, 285-295 (2015).
    • (2015) Cancer Cell , vol.28 , pp. 285-295
    • Dahan, R.1    Sega, E.2    Engelhardt, J.3    Selby, M.4    Korman, A.J.5    Ravetch, J.V.6
  • 26
    • 32044464340 scopus 로고    scopus 로고
    • The shaving reaction: Rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes
    • P. V. Beum, A. D. Kennedy, M. E. Williams, M. A. Lindorfer, R. P. Taylor, The shaving reaction: Rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes. J. Immunol. 176, 2600-2609 (2006).
    • (2006) J. Immunol. , vol.176 , pp. 2600-2609
    • Beum, P.V.1    Kennedy, A.D.2    Williams, M.E.3    Lindorfer, M.A.4    Taylor, R.P.5
  • 27
  • 28
    • 84921745242 scopus 로고    scopus 로고
    • Fcγ-receptor-mediated trogocytosis impacts mAb-based therapies: Historical precedence and recent developments
    • R. P. Taylor, M. A. Lindorfer, Fcγ-receptor-mediated trogocytosis impacts mAb-based therapies: Historical precedence and recent developments. Blood 125, 762-766 (2015).
    • (2015) Blood , vol.125 , pp. 762-766
    • Taylor, R.P.1    Lindorfer, M.A.2
  • 29
    • 65549114676 scopus 로고    scopus 로고
    • Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
    • P. Bruhns, B. Iannascoli, P. England, D. A. Mancardi, N. Fernandez, S. Jorieux, M. Daeron, Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses. Blood 113, 3716-3725 (2009).
    • (2009) Blood , vol.113 , pp. 3716-3725
    • Bruhns, P.1    Iannascoli, B.2    England, P.3    Mancardi, D.A.4    Fernandez, N.5    Jorieux, S.6    Daeron, M.7
  • 30
    • 84875998684 scopus 로고    scopus 로고
    • Impact of immune complex size and glycosylation on IgG binding to human FcγRs
    • A. Lux, X. Yu, C. N. Scanlan, F. Nimmerjahn, Impact of immune complex size and glycosylation on IgG binding to human FcγRs. J. Immunol. 190, 4315-4323 (2013).
    • (2013) J. Immunol. , vol.190 , pp. 4315-4323
    • Lux, A.1    Yu, X.2    Scanlan, C.N.3    Nimmerjahn, F.4
  • 38
    • 0034076307 scopus 로고    scopus 로고
    • Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets
    • R. A. Clynes, T. L. Towers, L. G. Presta, J. V. Ravetch, Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat. Med. 6, 443-446 (2000).
    • (2000) Nat. Med. , vol.6 , pp. 443-446
    • Clynes, R.A.1    Towers, T.L.2    Presta, L.G.3    Ravetch, J.V.4
  • 39
    • 84945555686 scopus 로고    scopus 로고
    • Novel radiotracer for immunoPET imaging of PD-1 checkpoint expression on tumor infiltrating lymphocytes
    • A. Natarajan, A. T. Mayer, L. Xu, R. E. Reeves, J. Gano, S. S. Gambhir, Novel radiotracer for immunoPET imaging of PD-1 checkpoint expression on tumor infiltrating lymphocytes. Bioconjug. Chem. 26, 2062-2069 (2015).
    • (2015) Bioconjug. Chem. , vol.26 , pp. 2062-2069
    • Natarajan, A.1    Mayer, A.T.2    Xu, L.3    Reeves, R.E.4    Gano, J.5    Gambhir, S.S.6
  • 40
    • 84982098636 scopus 로고    scopus 로고
    • High-resolution PET imaging with therapeutic antibody-based PD-1/PD-L1 checkpoint tracers
    • M. Hettich, F. Braun, M. D. Bartholomä, R. Schirmbeck, G. Niedermann, High-resolution PET imaging with therapeutic antibody-based PD-1/PD-L1 checkpoint tracers. Theranostics 6, 1629-1640 (2016).
    • (2016) Theranostics , vol.6 , pp. 1629-1640
    • Hettich, M.1    Braun, F.2    Bartholomä, M.D.3    Schirmbeck, R.4    Niedermann, G.5
  • 42
    • 85012158583 scopus 로고    scopus 로고
    • Primary, adaptive, and acquired resistance to cancer immunotherapy
    • P. Sharma, S. Hu-Lieskovan, J. A. Wargo, A. Ribas, Primary, adaptive, and acquired resistance to cancer immunotherapy. Cancer Cell 168, 707-723 (2017).
    • (2017) Cancer Cell , vol.168 , pp. 707-723
    • Sharma, P.1    Hu-Lieskovan, S.2    Wargo, J.A.3    Ribas, A.4
  • 46
    • 0030571019 scopus 로고    scopus 로고
    • A rapid high-resolution highperformance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles
    • G. R. Guile, P. M. Rudd, D. R. Wing, S. B. Prime, R. A. Dwek, A rapid high-resolution highperformance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal. Biochem. 240, 210-226 (1996).
    • (1996) Anal. Biochem. , vol.240 , pp. 210-226
    • Guile, G.R.1    Rudd, P.M.2    Wing, D.R.3    Prime, S.B.4    Dwek, R.A.5
  • 47
    • 0022532481 scopus 로고
    • Comparison of intravenous gamma globulin and a monoclonal anti-Fc receptor antibody as inhibitors of immune clearance in vivo in mice
    • R. J. Kurlander, J. Hall, Comparison of intravenous gamma globulin and a monoclonal anti-Fc receptor antibody as inhibitors of immune clearance in vivo in mice. J. Clin. Invest. 77, 2010-2018 (1986).
    • (1986) J. Clin. Invest. , vol.77 , pp. 2010-2018
    • Kurlander, R.J.1    Hall, J.2
  • 48
    • 84929624401 scopus 로고    scopus 로고
    • Single cell resolution in vivo imaging of DNA damage following PARP inhibition
    • K. S. Yang, R. H. Kohler, M. Landon, R. Giedt, R. Weissleder, Single cell resolution in vivo imaging of DNA damage following PARP inhibition. Sci. Rep. 5, 10129 (2015).
    • (2015) Sci. Rep. , vol.5 , pp. 10129
    • Yang, K.S.1    Kohler, R.H.2    Landon, M.3    Giedt, R.4    Weissleder, R.5
  • 49
    • 80053080677 scopus 로고    scopus 로고
    • Loss of CD20 and bound CD20 antibody from opsonized B cells occurs more rapidly because of trogocytosis mediated by Fc receptorexpressing effector cells than direct internalization by the B cells
    • P. V. Beum, E. M. Peek, M. A. Lindorfer, F. J. Beurskens, P. J. Engelberts, P. W. H. I. Parren, J. G. J. van de Winkel, R. P. Taylor, Loss of CD20 and bound CD20 antibody from opsonized B cells occurs more rapidly because of trogocytosis mediated by Fc receptorexpressing effector cells than direct internalization by the B cells. J. Immunol. 187, 3438-3447 (2011).
    • (2011) J. Immunol. , vol.187 , pp. 3438-3447
    • Beum, P.V.1    Peek, E.M.2    Lindorfer, M.A.3    Beurskens, F.J.4    Engelberts, P.J.5    Parren, P.W.H.I.6    Van De Winkel, J.G.J.7    Taylor, R.P.8
  • 50
    • 84929373209 scopus 로고    scopus 로고
    • Imaging windows for long-term intravital imaging: General overview and technical insights
    • M. Alieva, L. Ritsma, R. J. Giedt, R. Weissleder, Imaging windows for long-term intravital imaging: General overview and technical insights. IntraVital 3, e29917 (2014).
    • (2014) IntraVital , vol.3 , pp. e29917
    • Alieva, M.1    Ritsma, L.2    Giedt, R.J.3    Weissleder, R.4
  • 51
    • 0347717903 scopus 로고    scopus 로고
    • T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases
    • T. R. Mempel, S. E. Henrickson, U. H. von Andrian, T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427, 154-159 (2004).
    • (2004) Nature , vol.427 , pp. 154-159
    • Mempel, T.R.1    Henrickson, S.E.2    Von Andrian, U.H.3
  • 52
    • 22544487815 scopus 로고    scopus 로고
    • FcγRIV: A novel FcR with distinct IgG subclass specificity
    • F. Nimmerjahn, P. Bruhns, K. Horiuchi, J. V. Ravetch, FcγRIV: A novel FcR with distinct IgG subclass specificity. Immunity 23, 41-51 (2005).
    • (2005) Immunity , vol.23 , pp. 41-51
    • Nimmerjahn, F.1    Bruhns, P.2    Horiuchi, K.3    Ravetch, J.V.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.